The Journal of Practical Medicine >
Mycoplasma genitalium infection of patients attending sexually transmitted disease clinic in Guangzhou
Received date: 2023-11-30
Online published: 2024-05-21
Objective To assess the prevalence of mycoplasma genitalium (MG) in patients attending sexually transmitted disease (STD) clinic in Guangzhou, and to provide an epidemiological foundation for clinical treatment and laboratory diagnostics. Methods Utilizing real?time polymerase chain reaction (PCR), we analyzed MG DNA in 2,749 clinical specimens collected from 2,722 outpatients in the Dermatology Hospital of Southern Medical University from July 2019 to December 2021. Concurrent testing for MG, Chlamydia trachomatis(CT), and Neisseria gonorrhoeae (NG) was performed on 2,382 of these specimens. Patient data extracted from medical records were used to investigate the correlation between STD symptoms and MG infection. Results The investigation revealed that the overall prevalence of MG infection was 4.4 % among the sampled patients (120 out of 2,722), with a higher prevalence in males (4.9 %, or 87 out of 1,790) compared to in females (3.5 %, or 33 out of 932). Notably, the prevalence decreased with increasing age. The highest incidence of MG infection was observed in females aged 18 ~ 25 years (6.4 %, or 18 out of 281), while the lowest was in males aged 46 years and above (1.5 %, or 5 out of 342), showing a statistically significant variation across age groups (P < 0.05). Among males with urethritis symptoms, MG positive rate was significantly higher at 7.3 % (42 out of 574). The rate of single MG infection was prominent, accounting for 89.9 % (71 out of 79) in MG?positive male patients and 61.5 % (16 out of 26) in MG?positive female patients. Co?infection rate of MG with CT was 1.2 % in females and 0.3 % in males, indicating a significant difference (P < 0.05). Conclusion The findings suggest a relatively high prevalence of MG infection and co?infection with CT among STD clinic attendees in Guangzhou, particularly in the younger demographic. The study underscores the need for early screening and vigilant surveillance of MG to mitigate its transmission among sexually active populations at high risk.
Lei XU , Yinyuan LAN , Qian WU , Jinmei HUANG , Zhengqiang HE , Mingheng FANG , Jiangli OU , Xingzhong WU , Yaohua XUE , Bin. YANG . Mycoplasma genitalium infection of patients attending sexually transmitted disease clinic in Guangzhou[J]. The Journal of Practical Medicine, 2024 , 40(10) : 1434 -1439 . DOI: 10.3969/j.issn.1006-5725.2024.10.018
| 1 | TULLY J G, TAYLOR-ROBINSON D, COLE R M, et al. A newly discovered mycoplasma in the human urogenital tract[J]. Lancet, 1981,1(8233):1288-1291. doi:10.1016/s0140-6736(81)92461-2 |
| 2 | IWUJI C, PILLAY D, SHAMU P, et al. A systematic review of antimicrobial resistance in Neisseria gonorrhoeae and Mycoplasma genitalium in sub-Saharan Africa[J]. J Antimicrob Chemother, 2022,77(8):2074-2093. doi:10.1093/jac/dkac159 |
| 3 | KIRBY T. Mycoplasma genitalium: a potential new superbug[J]. Lancet Infect Dis, 2018,18(9):951-952. doi:10.1016/s1473-3099(18)30506-1 |
| 4 | FRENZER C, EGLI-GANY D, VALLELY L M, et al. Adverse pregnancy and perinatal outcomes associated with Mycoplasma genitalium: systematic review and meta-analysis[J]. Sex Transm Infect, 2022,98(3):222-227. doi:10.1136/sextrans-2021-055352 |
| 5 | JENSEN J S, CUSINI M, GOMBERG M, et al. 2021 European guideline on the management of Mycoplasma genitalium infections[J]. J Eur Acad Dermatol Venereol, 2022,36(5):641-650. doi:10.1111/jdv.17972 |
| 6 | 陈祥生, 姜婷婷. 我国性传播疾病的流行与防治[J]. 皮肤科学通报, 2021,38(1):1-7. |
| 7 | 徐青青, 陈文韬, 江银波, 等. 沙眼衣原体主要外膜蛋白多肽多克隆抗体的制备与鉴定[J]. 实用医学杂志, 2022,38(11):1333-1338. doi:10.3969/j.issn.1006?5725.2022.11.007 |
| 8 | JENSEN J S, CUSINI M, GOMBERG M, et al. 2016 European guideline on Mycoplasma genitalium infections[J]. J Eur Acad Dermatol Venereol, 2016,30(10):1650-1656. doi:10.1111/jdv.13849 |
| 9 | DUMKE R. Molecular Tools for Typing Mycoplasma pneumoniae and Mycoplasma genitalium[J]. Front Microbiol, 2022,13:904494. doi:10.3389/fmicb.2022.904494 |
| 10 | 张岱, 刘朝晖. 生殖道支原体感染诊治专家共识[J]. 中国性科学, 2016,25(3):80-82. |
| 11 | ZHANG X, ZHAO P, KE W, et al. Prevalence and correlates of Mycoplasma genitalium infection among patients attending a sexually transmitted infection clinic in Guangdong, China: a cross-sectional study[J]. BMC Infect Dis. 2021,21(1):649. doi:10.1186/s12879-021-06349-4 |
| 12 | NIFORATOS J D, ROTHMAN R E. Sexually Transmitted Infections Treatment Guidelines, 2021[J]. Ann Emerg Med, 2022,80(1):68-70. doi:10.1016/j.annemergmed.2022.05.017 |
| 13 | 张碧云, 陈颖悦, 胡阳, 等. 早孕期胚胎绒毛膜下血肿与下生殖道感染的关系[J]. 实用医学杂志, 2023,39(4):451-455. doi:10.3969/j.issn.1006-5725.2023.04.011 |
| 14 | 闫静敏, 姜南雁, 叶美萍, 等. 性病门诊女性就诊者中生殖支原体感染的患病率及相关因素[J]. 中国感染与化疗杂志, 2022,22(5):570-576. doi:10.16718/j.1009-7708.2022.05.008 |
| 15 | 李婷, 王昊泉. 2018-2020年杭州市泌尿生殖道炎症患者生殖支原体感染调查[J]. 中国微生态学杂志, 2022,34(9):1088-1090+1093. |
| 16 | 张琴, 程茂杰, 蒋有让, 等. 性病门诊非淋球菌性尿道炎及宫颈炎患者生殖支原体感染调查研究[J]. 重庆医学, 2019,48(8):1424-1425+1429. doi:10.3969/j.issn.1671-8348.2019.08.039 |
| 17 | MARTíN-SACO G, TRISTANCHO A, ARIAS A, et al. Mycoplasma genitalium and sexually transmitted infections: evidences and figures in a tertiary hospital[J]. Rev Esp Quimioter, 2022,35(1):76-79. doi:10.37201/req/091.2021 |
| 18 | BAUMANN L, CINA M, EGLI-GANY D, et al. Prevalence of Mycoplasma genitalium in different population groups: systematic review and meta-analysis[J]. Sex Transm Infect, 2018,94(4):255-262. doi:10.1136/sextrans-2017-053384 |
| 19 | MANHART L E, LEIPERTZ G, SOGE O O, et al. Mycoplasma genitalium in the US (MyGeniUS): Surveillance Data From Sexual Health Clinics in 4 US Regions[J]. Clin Infect Dis, 2023,77(10):1449-1459. doi:10.1093/cid/ciad405 |
| 20 | GNANADURAI R, FIFER H. Mycoplasma genitalium: A Review[J]. Microbiology, 2020,166(1):21-29. doi:10.1099/mic.0.000830 |
| 21 | ZHANG Z, ZONG X, BAI H, et al. Prevalence of Mycoplasma genitalium and Chlamydia trachomatis in Chinese female with lower reproductive tract infection: a multicenter epidemiological survey[J]. BMC Infect Dis, 2023,23(1):2. doi:10.1186/s12879-022-07975-2 |
| 22 | 唐盈, 林佩萱, 陈翊, 等. 广州地区女性患者泌尿生殖道CT,NG,MG和UU感染状况分析[J]. 现代检验医学杂志, 2019,34(5):146-149. doi:10.3969/j.issn.1671-7414.2019.05.037 |
| 23 | LILLIS R A, MARTIN D H, NSUAMI M J. Mycoplasma genitalium Infections in Women Attending a Sexually Transmitted Disease Clinic in New Orleans[J]. Clin Infect Dis, 2019,69(3):459-465. doi:10.1093/cid/ciy922 |
| 24 | TAYLOR-ROBINSON D, JENSEN J S. Mycoplasma genitalium: from Chrysalis to Multicolored Butterfly[J]. Clin Microbiol Rev, 2011,24(3):498-514. doi:10.1128/cmr.00006-11 |
| 25 | WIESENFELD H C, MANHART L E. Mycoplasma genitalium in Women: Current Knowledge and Research Priorities for This Recently Emerged Pathogen[J]. J Infect Dis, 2017,216():S389-S395. doi:10.1093/infdis/jix198 |
| 26 | BRAAM J F, VAN DAM A P, BRUISTEN S M, et al. Macrolide-Resistant Mycoplasma genitalium Impairs Clinical Improvement of Male Urethritis After Empirical Treatment[J]. Sex Transm Dis, 2022,49(5):360-367. doi:10.1097/olq.0000000000001591 |
| 27 | YUSUF E, MERTENS K, VAN LISDONK N, et al. Epidemiology of Mycoplasma genitalium and Trichomonas vaginalis in the primary health care setting in the Netherlands[J]. Epidemiol Infect, 2023,151:e79. doi:10.1017/s095026882300064x |
/
| 〈 |
|
〉 |